Insmed (INSM) Tax Rate Growth (3y) (2014 - 2026)

Insmed (INSM) Tax Rate Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,094.26 Bn 68,093.97 Bn -
2 Nanobiotix 1,939.09 Bn 1,939.02 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 473.53 Bn 468.74 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.34 Bn 116.09 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.13 Bn 61.38 Bn 3.31 Bn
7 Belite Bio 62.96 Bn 62.96 Bn -
8 Argenx Se 56.38 Bn 51.20 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.67 Bn 34.66 Bn 959.66 Mn
10 Insmed 23.04 Bn 21.82 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -62.00
Dec 31, 2025 -38.00
Sep 30, 2025 -7.00
Jun 30, 2025 14.00
Mar 31, 2025 6.00
Dec 31, 2024 -63.00
Sep 30, 2024 -270.00
Jun 30, 2024 25.00
Mar 31, 2024 -16.00
Dec 31, 2023 5.00
Sep 30, 2023 16.00
Jun 30, 2023 45.00
Dec 31, 2022 58.00
Sep 30, 2022 -12.00
Jun 30, 2022 -38.00
Mar 31, 2022 -14.00
Dec 31, 2021 15.00
Sep 30, 2021 229.00
Jun 30, 2021 -46.00
Dec 31, 2020 -115.00